Overview of CRISPR-Cas Mediated Genome Engineering
T. G. Bhuvana & N. Ranjitha · Journal of Applied Life Sciences International · 2022
Genetic diseases are prevailing in 3-5% of new-born worldwide and estimated to cause around 50% of child deaths. The development of efficient and regulated system for customizing genome modifications to treat such disorders has been the zone of interest. Over time, different edit...
Open access
Research Article
10.9734/jalsi/2022/v25i6583